{"id":"https://openalex.org/W2536634671","doi":"https://doi.org/10.1182/blood.v126.23.2510.2510","title":"CPX-351 ((Cytarabine:Daunorubicin) Liposome Injection, (Vyxeos)) Does Not Prolong Qtcf Intervals, Requires No Dose Adjustment for Impaired Renal Function and Induces High Rates of Complete Remission in Acute Myeloid Leukemia","display_name":"CPX-351 ((Cytarabine:Daunorubicin) Liposome Injection, (Vyxeos)) Does Not Prolong Qtcf Intervals, Requires No Dose Adjustment for Impaired Renal Function and Induces High Rates of Complete Remission in Acute Myeloid Leukemia","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2536634671","doi":"https://doi.org/10.1182/blood.v126.23.2510.2510","mag":"2536634671"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.2510.2510","doi":"https://doi.org/10.1182/blood.v126.23.2510.2510","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2510.2510","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035236340","display_name":"Tara L. Lin","orcid":"https://orcid.org/0000-0002-0242-6449","observed_orcids":["https://orcid.org/0000-0002-0242-6449"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tara L. Lin","raw_affiliation_strings":["University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083412651","display_name":"Laura F. Newell","orcid":"https://orcid.org/0000-0001-9012-3167","observed_orcids":["https://orcid.org/0000-0001-9012-3167"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura F. Newell","raw_affiliation_strings":["Center for Hematologic Malignancies, Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Hematologic Malignancies, Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015493242","display_name":"Robert Kenneth Stuart","orcid":"https://orcid.org/0000-0001-7549-8008","observed_orcids":["https://orcid.org/0000-0001-7549-8008"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert K. Stuart","raw_affiliation_strings":["Medical University of South Carolina, Charleston, SC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of South Carolina, Charleston, SC","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022002706","display_name":"Laura Christian Michaelis","orcid":"https://orcid.org/0000-0002-1798-9658","observed_orcids":["https://orcid.org/0000-0002-1798-9658"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura C. Michaelis","raw_affiliation_strings":["Medical College of Wisconsin, Milwaukee, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical College of Wisconsin, Milwaukee, WI","institution_ids":["https://openalex.org/I204308271"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086481106","display_name":"S. Eric Rubenstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100718","display_name":"Franciscan Health Indianapolis","ror":"https://ror.org/018x1j412","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799894082","https://openalex.org/I4210100718"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen E. Rubenstein","raw_affiliation_strings":["St. Francis Medical Group, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Francis Medical Group, Indianapolis, IN","institution_ids":["https://openalex.org/I4210100718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025358448","display_name":"Helen S. Pentikis","orcid":"https://orcid.org/0009-0001-7544-0540","observed_orcids":["https://orcid.org/0009-0001-7544-0540"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Helen S. Pentikis","raw_affiliation_strings":["SAJE Consulting, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SAJE Consulting, Baltimore, MD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053681862","display_name":"Timothy S. Callahan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Timothy Callahan","raw_affiliation_strings":["Biomedical Systems, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Systems, St. Louis, MO","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079677766","display_name":"Donna Alvarez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Donna Alvarez","raw_affiliation_strings":["Celator Pharmaceuticals, Inc., Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celator Pharmaceuticals, Inc., Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109840679","display_name":"Lawrence D. Mayer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Lawrence D. Mayer","raw_affiliation_strings":["Celator Pharmaceuticals, Inc., Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celator Pharmaceuticals, Inc., Ewing, NJ","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110481152","display_name":"Arthur Chin Louie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arthur C. Louie","raw_affiliation_strings":["Celator Pharmaceuticals, Inc., Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celator Pharmaceuticals, Inc., Ewing, NJ","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5025358448","https://openalex.org/A5053681862","https://openalex.org/A5079677766","https://openalex.org/A5109840679"],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"2510","last_page":"2510"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9218999743461609,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9218999743461609,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.013100000098347664,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cpx-351","display_name":"CPX-351","score":0.9860000014305115},{"id":"https://openalex.org/keywords/vyxeos","display_name":"Vyxeos","score":0.9409999847412109},{"id":"https://openalex.org/keywords/liposomal-cytarabine","display_name":"liposomal cytarabine","score":0.9369999766349792},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.9509999752044678},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.972000002861023},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.7900000214576721},{"id":"https://openalex.org/keywords/cardiac-repolarization","display_name":"cardiac repolarization","score":0.9819999933242798},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7929999828338623},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9269999861717224},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.8159999847412109},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.9539999961853027},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.921999990940094},{"id":"https://openalex.org/keywords/daunorubicinol","display_name":"daunorubicinol","score":0.7400000095367432},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.7059999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8781270980834961},{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.6366862654685974},{"id":"https://openalex.org/C118441451","wikidata":"https://www.wikidata.org/wiki/Q12074763","display_name":"QT interval","level":2,"score":0.568407416343689},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.567211925983429},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5323598384857178},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46923309564590454},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4367494285106659},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.41111665964126587},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3886169195175171},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.24554568529129028},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.20246165990829468}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.2510.2510","doi":"https://doi.org/10.1182/blood.v126.23.2510.2510","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2510.2510","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2945230153","https://openalex.org/W4385667344","https://openalex.org/W4379345932","https://openalex.org/W4416673000","https://openalex.org/W3029681944","https://openalex.org/W2593940398","https://openalex.org/W2087703306","https://openalex.org/W4399688745","https://openalex.org/W2162351643","https://openalex.org/W3096295699"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"CPX-351":[2,36,106,143,218,255,291,443,509,511],"is":[3,19,504,527],"a":[4,13,230,506],"liposomal":[5],"formulation":[6],"of":[7,35,208,232,249,254,258,284,389,408,430,437,502,508,515,532,543,571,583,594],"cytarabine":[8,246],"and":[9,49,55,69,84,101,109,131,154,162,187,201,211,227,247,277,385,395,405,424,465,535],"daunorubicin":[10,248],"encapsulated":[11],"at":[12],"fixed":[14],"5:1":[15],"molar":[16],"ratio.":[17],"It":[18],"highly":[20],"effective":[21],"in":[22,206,461,546],"patients":[23,60,127,210,392,400,418,438],"with":[24,61,240,262,275,442,549],"high-risk":[25],"acute":[26,56],"myeloid":[27],"leukemia":[28,58,421],"(AML).":[29],"This":[30,43],"study":[31,52,130],"evaluated":[32],"the":[33,92,113,117,129,145,237,540],"impact":[34],"(100":[37],"units/m2)":[38],"on":[39,173,288,412,567,579,590],"cardiac":[40,71],"repolarization.":[41],"Methods:":[42],"open-label,":[44],"Phase":[45],"II,":[46],"pharmacokinetic":[47],"(PK)":[48],"pharmacodynamic":[50],"(PD)":[51],"entered":[53,128],"AML":[54,399],"lymphocytic":[57],"(ALL)":[59],"good":[62],"risk":[63],"hepatic":[64],"function":[65,72,111,268,286,526],"(Child-Pugh":[66],"scores":[67],"<7),":[68],"normal":[70,278],"(LVEF\u226550%,":[73],"QTcF<470":[74],"ms).":[75],"Cardiac":[76],"repolarization":[77],"changes":[78,213],"were":[79,133,184,194,204,216,402,425],"assessed":[80,90],"using":[81,112],"conventional":[82],"ECG":[83],"Holter":[85],"monitor":[86],"recordings.":[87],"PK":[88,253,292],"was":[89,123,148,160,176,256,396,432,513],"during":[91],"first":[93],"21":[94,132],"days":[95],"for":[96,135,224,245,448,521,537],"total":[97],"cytarabine,":[98],"daunorubicin,":[99],"Ara-U":[100],"daunorubicinol.":[102],"The":[103,151,252,529],"relationship":[104],"between":[105,199],"PK,":[107],"QTcF,":[108],"renal":[110,259,267,279,285,516,525],"equation":[114],"to":[115,236,413],"calculate":[116],"estimated":[118],"glomerular":[119],"filtration":[120],"rate":[121,531],"(eGFR)":[122],"evaluated.":[124],"Results:":[125],"Twenty-six":[126],"evaluable":[134],"QT":[136],"interval":[137,147],"change":[138,156,172],"from":[139,157,178],"baseline.":[140,179],"Evidence":[141],"that":[142],"prolongs":[144],"QTcF":[146,171,180,190,197,503],"not":[149,505],"observed.":[150,217],"largest":[152],"absolute":[153],"mean":[155],"time-matched":[158],"baseline":[159],"12.56":[161],"8.03":[163],"ms,":[164],"respectively":[165],"(Day":[166],"1,":[167],"hour":[168],"4).":[169],"Mean":[170,310,322,334,347,359,371],"Day":[174,289],"5":[175,228,290,487],"unchanged":[177],"intervals":[181,191],">480":[182],"ms":[183,193,203,215],"never":[185],"observed":[186,545],"no":[188,212,519],"consistent":[189],">450":[192],"noted.":[195],"Absolute":[196],"increases":[198],"30":[200],"60":[202],"present":[205],"4":[207],"25":[209],">60":[214],"plasma":[219,238],"concentration":[220],"vs.":[221],"time":[222],"curves":[223],"day":[225],"1":[226,474,482,490,491],"exhibited":[229,269],"volume":[231,239],"distribution":[233],"approximately":[234],"equal":[235],"prolonged":[241],"single-exponential":[242],"elimination":[243],"half-lives":[244],"\u226524":[250],"hours.":[251],"independent":[257,514],"function.":[260,280],"Patients":[261],"moderately":[263],"impaired":[264],"(eGFR=30-59":[265],"mL/min/1.73m2)":[266],"similar":[270],"drug":[271],"exposure":[272,512],"as":[273],"those":[274],"mild":[276],"Table":[281,381,452],"1.":[282],"Impact":[283],"impairment":[287],"parameters":[293],"(mean,":[294],"%CV):":[295],"Analyte":[296],"Renal":[297],"Function":[298],"Cmax":[299],"(ng/mL)":[300],"AUClast":[301],"(ng*hr/mL)":[302,304],"AUCinf":[303],"T1/2":[305],"(hr)":[306],"Cytarabine":[307],"Normal":[308,345],"(n=3)":[309,333,346,370],"59333":[311],"2893146":[312],"2902641":[313],"42.5":[314],"%CV":[315,327,339,352,364,376],"28.7":[316],"68.8":[317],"69":[318],"34.1":[319],"Mild":[320,357],"(n=7)":[321,358],"58071":[323],"3599512":[324],"3606695":[325],"41.0":[326],"31.9":[328],"52.4":[329,330],"21.8":[331],"Moderate":[332,369],"57333":[335],"3149303":[336],"3156738":[337],"38.0":[338],"46.6":[340],"50.7":[341],"50.6":[342],"21.9":[343],"Daunorubicin":[344],"25967":[348],"754646":[349],"870861":[350],"24.9":[351],"23.1":[353],"63":[354],"65.3":[355],"56.0":[356],"28686":[360],"865034":[361],"1021420":[362],"30.5":[363],"43.9":[365],"43.5":[366],"43.6":[367],"25.3":[368],"21933":[372],"671542":[373],"814732":[374],"35.4":[375],"50.9":[377],"35.9":[378],"33.5":[379],"31.2":[380],"2":[382,406,470,483,496],"summarizes":[383],"response":[384],"transplant":[386,449,538],"outcomes.":[387],"One":[388],"two":[390],"ALL":[391],"achieved":[393],"CR":[394,404,431],"transplanted.":[397],"Among":[398],"there":[401],"7":[403],"CRi":[407],"which":[409],"three":[410],"went":[411],"transplant.":[414],"An":[415],"additional":[416],"four":[417],"became":[419,446],"morphologically":[420],"free":[422],"(MLF)":[423],"transplanted":[426],"before":[427],"full":[428],"documentation":[429],"achieved.":[433],"A":[434],"large":[435],"majority":[436],"given":[439],"first-line":[440],"treatment":[441],"responded":[444],"or":[445,573,585,596],"suitable":[447],"(10/13,":[450],"77%).":[451],"2.":[453],"206":[454],"Study":[455],"Efficacy":[456],"Diagnosis":[457],"n":[458],"ResponseCR/CRi":[459],"Transplanted":[460,466],"CR/CRi":[462],"Induced":[463],"MLF":[464],"No":[467],"Response":[468],"ALL-Relapsed":[469],"1/0":[471,472,494,495],"0":[473,481],"AML-First":[475,484],"Line":[476,485],"de":[477],"novo":[478],"8":[479,497],"5/0":[480],"sAML":[486],"1/2":[488],"1/1":[489],"AML-Salvage":[492],"11":[493],"Conclusions:":[498],"Clinically":[499],"relevant":[500],"prolongation":[501],"feature":[507],"treatment.":[510],"function,":[517],"indicating":[518],"need":[520],"dose":[522],"adjustment":[523],"when":[524],"impaired.":[528],"high":[530,541],"complete":[533],"remission":[534],"referral":[536],"corroborate":[539],"level":[542],"efficacy":[544],"earlier":[547],"studies":[548],"CPX-351.":[550],"Disclosures":[551],"Stuart:":[552],"Sunesis:":[553],"Honoraria,":[554],"Other:":[555],"Advisory":[556],"Board,":[557],"Research":[558,563],"Funding;":[559],"Astellas":[560],"Pharma,":[561],"Inc:":[562],"Funding.":[564],"Michaelis:Incyte:":[565],"Membership":[566,578,589],"an":[568,580,591],"entity's":[569,581,592],"Board":[570,582,593],"Directors":[572,584,595],"advisory":[574,586,597],"committees;":[575,587,598],"CTI":[576],"Biopharma:":[577],"Wyeth:":[588],"Pfizer:":[599],"Equity":[600,609,615,621],"Ownership.":[601,610,616,622],"Pentikis:Celator":[602],"Pharmaceuticals:":[603],"Consultancy.":[604],"Alvarez:Celator":[605],"Pharmaceuticals,":[606,612,618],"Inc.:":[607,613,619],"Employment,":[608,614,620],"Mayer:Celator":[611],"Louie:Celator":[617]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2016-10-28T00:00:00"}